Clinical Trial: A Study to Assess the Bioequivalence of Efgartigimod PH20 SC Between Autoinjector and Prefilled Syringe in Healthy Adult Participants

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07782775) titled 'A Study to Assess the Bioequivalence of Efgartigimod PH20 SC Between Autoinjector and Prefilled Syringe in Healthy Adult Participants' on Aug. 20.

Brief Summary: The aim of this study is to compare the amount of efgartigimod in the blood over time after it is injected via Prefilled syringe (PFS) and Autoinjector (AI).

The study will comprise 2 study periods of 3 weeks each. Each participant receives both efgartigimod PH20 SC AI and PFS treatments, in a different order.

Participants will be in the study for up to approximately 9 weeks.

Study Start Date: June 19

Study Type: INTERVENTIONAL

Condition: Healthy Volunteer Healthy Adu...